US Stock MarketDetailed Quotes
PETS PetMed Express
- 4.700
- +0.030+0.64%
Close Nov 27 16:00 ET
- 4.820
- +0.120+2.55%
Post 20:01 ET
97.12MMarket Cap-78333P/E (TTM)
4.810High4.670Low76.96KVolume4.720Open4.670Pre Close363.29KTurnover0.46%Turnover RatioLossP/E (Static)20.66MShares7.90052wk High1.01P/B79.57MFloat Cap2.90052wk Low--Dividend TTM16.93MShs Float48.951Historical High--Div YieldTTM3.00%Amplitude0.047Historical Low4.720Avg Price1Lot Size
PetMed Express Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1,050.97%7.39M | -1,615.48%-8.52M | -84.47%4.32M | -26.72%7.13M | -120.00%-2.59M | 38.92%-777K | -91.19%562K | 50.30%27.8M | 11.55%9.72M | 48.99%12.97M |
| Net income from continuing operations | 225.31%2.33M | 430.46%3.75M | -245.21%-7.46M | -2,222.22%-5.02M | -101,450.00%-2.03M | -73.19%715K | -142.28%-1.14M | -72.54%5.14M | -105.87%-216K | -99.95%2K |
| Depreciation and amortization | -3.21%1.66M | 2.56%1.72M | 98.98%7.06M | 90.64%1.9M | 88.10%1.77M | 99.65%1.71M | 122.84%1.68M | 29.51%3.55M | 44.69%994K | 32.54%941K |
| Deferred tax | -239.29%-670K | 95.85%-26K | 117.91%292K | 241.09%728K | 60.00%-290K | 24.29%481K | 19.20%-627K | -92.67%-1.63M | 37.61%-516K | -98.63%-725K |
| Change In working capital | 163.84%3.47M | -421.55%-5.9M | -119.83%-2.76M | -4.24%7.58M | -135.06%-3.77M | 21.12%-5.43M | -153.02%-1.13M | 303.93%13.92M | 119.42%7.91M | 310.89%10.76M |
| -Change in receivables | 303.34%608K | 2,013.04%880K | -4,148.78%-1.74M | -673.50%-1.62M | 138.90%226K | -274.85%-299K | -153.49%-46K | -108.06%-41K | 140.03%283K | -207.39%-581K |
| -Change in inventory | -7.41%12.43M | 129.81%3.04M | -147.77%-6.42M | 78.19%6.02M | -234.90%-15.68M | 217.25%13.42M | -203.09%-10.19M | 583.56%13.43M | 170.18%3.38M | 246.96%11.62M |
| -Change in prepaid assets | 83.48%-171K | 229.54%2.66M | 1,500.00%490K | 85.75%3.09M | 141.36%491K | 37.01%-1.04M | -281.54%-2.06M | 58.82%-35K | 460.74%1.66M | -665.24%-1.19M |
| -Change in payables and accrued expense | 50.16%-8.9M | -210.24%-12.03M | 842.32%5.28M | -78.80%548K | 1,191.16%11.69M | -396.14%-17.87M | 221.72%10.91M | 106.08%560K | -73.04%2.59M | -90.74%905K |
| -Change in other current assets | -44.44%110K | -31.12%135K | --788K | --194K | --200K | --198K | --196K | --0 | --0 | --0 |
| -Change in other current liabilities | 39.89%-107K | 35.12%-133K | ---766K | ---189K | ---194K | ---178K | ---205K | --0 | --0 | --0 |
| -Change in other working capital | -252.15%-496K | -280.63%-457K | ---390K | ---465K | ---504K | --326K | --253K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1,050.97%7.39M | -1,615.48%-8.52M | -84.47%4.32M | -26.73%7.13M | -119.99%-2.59M | 38.92%-777K | -91.19%562K | 50.30%27.8M | 11.55%9.72M | 48.99%12.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -28.56%-1.27M | 98.15%-683K | -296.39%-40.67M | 35.21%-1.25M | -43.30%-1.42M | 27.33%-984K | -518.72%-37.01M | -485.62%-10.26M | -297.33%-1.93M | -237.76%-993K |
| Net PPE purchase and sale | -28.56%-1.27M | 40.76%-683K | 14.24%-4.51M | 35.21%-1.25M | -13.09%-1.12M | 27.33%-984K | -17.41%-1.15M | -200.23%-5.26M | -297.33%-1.93M | -237.76%-993K |
| Net business purchase and sale | --0 | --0 | -623.18%-36.16M | --0 | ---300K | --0 | -617.18%-35.86M | ---5M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -28.56%-1.27M | 98.15%-683K | -296.39%-40.67M | 35.21%-1.25M | -43.30%-1.42M | 27.33%-984K | -518.72%-37.01M | -485.62%-10.26M | -297.33%-1.93M | -237.76%-993K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 98.87%-71K | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M |
| Cash dividends paid | 98.87%-71K | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 98.87%-71K | 98.30%-104K | 49.31%-12.44M | 99.71%-18K | 99.75%-15K | -0.96%-6.3M | -0.63%-6.1M | -0.63%-24.54M | -1.20%-6.14M | -0.54%-6.1M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.26%45.99M | -46.87%55.3M | -6.30%104.09M | -51.73%49.44M | -44.62%53.47M | -41.63%61.53M | -6.30%104.09M | -6.43%111.08M | -5.95%102.43M | -9.40%96.55M |
| Current changes in cash | 175.07%6.05M | 78.13%-9.3M | -597.60%-48.79M | 253.20%5.86M | -168.53%-4.03M | 9.08%-8.06M | -651.01%-42.55M | 8.43%-6.99M | -23.56%1.66M | 150.40%5.88M |
| End cash Position | -2.67%52.05M | -25.26%45.99M | -46.87%55.3M | -46.87%55.3M | -51.73%49.44M | -44.62%53.47M | -41.63%61.53M | -6.30%104.09M | -6.30%104.09M | -5.95%102.43M |
| Free cash flow | 447.76%6.12M | -1,456.68%-9.2M | -100.86%-194K | -24.62%5.87M | -131.02%-3.72M | 32.94%-1.76M | -110.95%-591K | 34.62%22.54M | -5.32%7.79M | 42.39%11.98M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data